Labshake search
Citations for Bio X Cell :
1551 - 1600 of 2218 citations since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2021Quote: ... (2) aged-matched control mice (n=7) that received weekly IP injections of the isotype control IgG2A antibody (2A3, Bio X Cell, Lebanon, NH) at 12 mg/kg for 8 weeks ...
-
bioRxiv - Cell Biology 2021Quote: ... anti-PD-1 antibody-injected group (n=12) that received weekly IP injections of InVivoMAb anti-mouse PD-1 antibody (RMP1-14, Bio X Cell, Lebanon, NH) at 12 mg/kg for 8 weeks ...
-
bioRxiv - Bioengineering 2021Quote: Mouse isotype IgG (BioXCell; BE0083, clone MOPC-21) and human IL-12 (Sino Biological ...
-
bioRxiv - Bioengineering 2021Quote: ... Mouse IgG1 isotype control antibody (clone MOPC-21) was purchased from Bio X Cell. Tag-free and histidine tagged human IL-12 were both purchased from Sino Biologicals.
-
bioRxiv - Microbiology 2021Quote: ... Antibodies specific for PR8 hemagglutinin protein (NR-3148, BEI Resources) and Ly6G (1A8, Bio X Cell) were detected with immPACT vector red and immPACT DAB ...
-
bioRxiv - Microbiology 2021Quote: Signaling by interferon alpha receptor 1 (IFNAR1) was inhibited by treating mice with 0.05 mg anti-IFNAR1 antibody (MAR1-5A3, Bio X Cell) intranasally on days -2 and 0 with virus or mock inoculations ...
-
bioRxiv - Immunology 2021Quote: ... control antibody (LTF-2, BioXCell), rabbit anti-human CRT (ab2907 ...
-
bioRxiv - Immunology 2021Quote: ... Anti-CSF-1R Mab (400 µg/dose; Clone: AFS98; Bio X Cell) was given every other day ...
-
bioRxiv - Immunology 2021Quote: ... CTLs were pre-incubated with LFA-1 blocking antibody (20 μg/mL, Clone M17/4, BioXCell) or an IgG2aκ isotype control antibody (20 μg/mL ...
-
bioRxiv - Microbiology 2021Quote: ... or human IgG1 isotype control (BioXCell, #BE0297) for 30 min at 4°C ...
-
bioRxiv - Microbiology 2021Quote: ... or human IgG1 isotype (BioXCell, #BE0297) (as negative control ...
-
bioRxiv - Immunology 2021Quote: ... mice were treated once with 2 mg of blocking antibodies one day prior to infection (Clone MAR1-5A3; BioXCell). Experiments involving SARS-CoV-2 infection were performed in a Biosafety Level 3 (BSL-3 ...
-
bioRxiv - Immunology 2021Quote: ... α-ICAM-1 (YN1/1.7.4) (BioXCell), α- VCAM-1 (Phe25-Glu698 ...
-
bioRxiv - Immunology 2021Quote: ... injected with 100 μg α-CD62L (MEL14) (BioXCell), and control mice with PBS alone ...
-
bioRxiv - Microbiology 2021Quote: ... anti-mouse Nk1.1 (clone PK136, BioXcell), and control anti-keyhole limpet hemocyanin (clone LTF-2 ...
-
bioRxiv - Microbiology 2021Quote: ... and control anti-keyhole limpet hemocyanin (clone LTF-2, BioXcell). Antibodies used for protein quantification for ELISAs were mouse monoclonal anti-His (His-Tag mAb ...
-
bioRxiv - Microbiology 2021Quote: ... and IgG2a (C1.18.4, BioXcell). Antibodies used for in vivo leukocyte cell depletion were ...
-
bioRxiv - Microbiology 2021Quote: ... Mouse isotype control antibodies were: IgG1 (MOPC-21, BioXcell) and IgG2a (C1.18.4 ...
-
bioRxiv - Microbiology 2021Quote: ... Antibodies used for in vivo leukocyte cell depletion were: anti-mouse Cd4 (clone GK1.5, BioXcell), anti-mouse Cd8 (clone 2.43 ...
-
bioRxiv - Microbiology 2021Quote: ... anti-mouse Cd8 (clone 2.43, BioXcell), anti-mouse Nk1.1 (clone PK136 ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... or anti-podoplanin antibody (Bioxcell InvivoMab, BE0236, 100μg/mouse) in Chi3l1-/- reconstituted with rmChi3l1 at 16h prior to APAP treatment.
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... injected with Ctrl IgG (Bioxcell InvivoMab, BE0087, 100μg/mouse) or anti-podoplanin antibody (Bioxcell InvivoMab ...
-
bioRxiv - Microbiology 2021Quote: ... 50 μl of rat anti-CD16/CD32 (Fc block, clone 2.4 G2, Bioxcell, Lebanon NH), at 1 μg/ml ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 0.25 mg anti-H2Kb (Y3, BioXCell) were immobilized on each Protein-A cartridge (25 µL bed volume ...
-
bioRxiv - Immunology 2021Quote: ... isotype-matched rat antibodies against HRPN were used (Clone LTF-2;; Cat#BE0090: BioXCell).
-
bioRxiv - Cancer Biology 2021Quote: ... The anti-PD1 (clone RMP1-14, Ref: BE0146) was purchased from BioXcell and treatment started at day 10 post-transplantation when the average tumor volume was of 40-70 mm3 ...
-
bioRxiv - Genomics 2021Quote: ... 15 μg/g of anti-NK1.1 (clone PK136, BioXCell) was injected intraperitoneally every three days beginning at postnatal day five ...
-
bioRxiv - Cancer Biology 2021Quote: ... αCTLA (9H10, BioXCell) was administered at an initial dose of 200 μg ...
-
bioRxiv - Cancer Biology 2021Quote: ... and αCD8 (2.43, BioXCell) depleting antibodies were administered at 200 ug every 4 days ...
-
bioRxiv - Cancer Biology 2021Quote: ... αPD-1 (29F.1A12, BioXCell) was administered at 200 μg three times a week ...
-
bioRxiv - Cancer Biology 2021Quote: ... anti-4-1BB agonist (5 mg/kg, clone: 3H3, BioXcell), or anti-PD-1 (10 mg/kg ...
-
bioRxiv - Cancer Biology 2021Quote: ... or anti-PD-1 (10 mg/kg, clone: RMP1-14, BioXcell) on day 10 ...
-
bioRxiv - Cancer Biology 2021Quote: ... αCD4 (GK1.5, BioXCell) and αCD8 (2.43 ...
-
bioRxiv - Cancer Biology 2021Quote: Mice were treated with either IgG (5 mg/kg as an anti-4-1BB control, 10 mg/kg as an anti-PD-1 control, BioXcell), anti-4-1BB agonist (5 mg/kg ...
-
bioRxiv - Cancer Biology 2021Quote: ... Isotype-matched control antibody rat IgG2a (BioXCell, BE0089) and rat anti-PD1 antibody (BioXCell ...
-
bioRxiv - Cancer Biology 2021Quote: ... and rat anti-PD1 antibody (BioXCell, BE0146) were given intraperitoneally at a dose of 200 μg per mouse on day 4 after cell inoculation ...
-
bioRxiv - Immunology 2021Quote: ... mice were treated with 200μg of CD71 blocking antibody (clone R17 217.1.3/TIB-219) or an isotype control antibody starting at 4-4.5 months of age (BioxCell). Treatment was administered twice a week via IP injection for 4 weeks.
-
bioRxiv - Immunology 2021Quote: ... cells were activated in the presence of either 2μg/mL anti-human CD71 (clone OKT9, BioXCell) or mouse IgG1 isotype control (clone MOPC-21).
-
bioRxiv - Cancer Biology 2021Quote: ... PD-L2 (InVivoMAb; BioXcell, West Lebanon, NH), CC10 ...
-
bioRxiv - Cancer Biology 2021Quote: ... mice were administered 100µg anti-NK1.1 antibody (BioXCell InVivoPlus, clone PK136, lot# 693118K3) or vehicle control every 4 days until endpoint was reached ...
-
bioRxiv - Cancer Biology 2021Quote: ... mice were administered 300µg of both anti-CD19 (BioXCell InVivoMAb, clone 1D3, lot# 701318J3) and anti-B220 (BioXCell InVivoMab ...
-
bioRxiv - Cancer Biology 2021Quote: ... or 400 µg of anti-IgG2b isotype control (BioXCell BE0090), was used for CD8/CD4 dual depletion ...
-
bioRxiv - Cancer Biology 2021Quote: ... 250 μg PD-1 and CTLA-4 blocking (clone 9H10, BioXCell, Lebanon, NH) antibodies were injected intraperitoneally thrice per week for four weeks or a combination of PD-1 CTLA-4 antibodies with iBET762 were used.
-
bioRxiv - Cancer Biology 2021Quote: ... 200 μg PD-1-blocking antibody-injected (clone RMP1-14, BioXCell, Lebanon, NH) intraperitoneally twice per week for three weeks ...
-
bioRxiv - Cancer Biology 2021Quote: Neutrophils were depleted using 75 µg αLy6G (clone 1A8; BioXCell) followed by 150 µg mouse anti-RAT (clone MAR18.5 ...
-
bioRxiv - Cancer Biology 2021Quote: ... or murine IgG1 isotype control (clone MOPC-21; BioXCell) were administered IP in a volume of 100 µL HBSS when tumours reached approximately 100 mm3 with additional doses being administered weekly ...
-
bioRxiv - Cancer Biology 2021Quote: ... a single dose of 100 µg of αCD40 (clone: FGK4.5; BioXCell) agonist antibody or rat IgG2a isotype control (clone 2A3 ...
-
bioRxiv - Cancer Biology 2021Quote: ... agonist antibody or rat IgG2a isotype control (clone 2A3; BioXCell) was administered intraperitoneally (IP ...
-
bioRxiv - Cancer Biology 2021Quote: ... or murine IgG2a (clone 2A3; BioXCell) were administered IP in a volume of 100 µL HBSS once at day 4 post tumour implantation.
-
bioRxiv - Cancer Biology 2021Quote: ... 30 µg of Flt-3L-Ig (hum/hum) (clone Flt-3L Fc-G1; BioXCell) was administered IP in a volume of 50 µL HBSS every 24 hours between day 0 and day 8 post LLC tumour implantation.